{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:09:57Z","timestamp":1791331797661,"version":"4.3.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health Research Biomedical Research Centre"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.kint.2018.09.027","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T08:07:31Z","timestamp":1547453251000},"page":"655-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis"],"prefix":"10.1016","volume":"95","author":[{"given":"Hannah R.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Medjeral-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa C.","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritesh","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Seyb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Farzaneh-Far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Zickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Lightstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Terence","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.09.027_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2012.08.018","article-title":"Lupus nephritis: a critical review","volume":"12","author":"Borchers","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.kint.2018.09.027_bib2","unstructured":"Aurinia Pharmaceuticals. Aurinia announces voclosporin meets 48-week remission endpoints, achieving highest complete remission rate of any global lupus nephritis study. Available at: http:\/\/ir.auriniapharma.com\/press-releases\/detail\/73. Accessed July 25,\u00a02017."},{"key":"10.1016\/j.kint.2018.09.027_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ekir.2016.06.005","article-title":"Complement-mediated glomerular diseases: a tale of 3 pathways","volume":"1","author":"Bomback","year":"2016","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2018.09.027_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/0961203311415561","article-title":"Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis","volume":"20","author":"Sato","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2018.09.027_bib5","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1073\/pnas.93.16.8563","article-title":"Amelioration of lupus-like autoimmune disease in NZB\/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5","volume":"93","author":"Wang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.09.027_bib6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00296-017-3686-5","article-title":"Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence","volume":"37","author":"Sciascia","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.kint.2018.09.027_bib7","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1084\/jem.154.6.1779","article-title":"Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis","volume":"154","author":"Biesecker","year":"1981","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2018.09.027_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1172\/JCI111004","article-title":"Neoantigen of the polymerized ninth component of complement","volume":"72","author":"Falk","year":"1983","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2018.09.027_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2249.1996.d01-776.x","article-title":"CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients","volume":"105","author":"Teixeira","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2018.09.027_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.humimm.2013.04.030","article-title":"Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients","volume":"74","author":"Nisihara","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.kint.2018.09.027_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2018.01.004","article-title":"Membrane attack complex (MAC) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment","volume":"48","author":"Wang","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.kint.2018.09.027_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/clin.1995.1040","article-title":"The value of complement activation products in the assessment of systemic lupus erythematosus flares","volume":"74","author":"Porcel","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.kint.2018.09.027_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10875-009-9344-2","article-title":"Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis","volume":"30","author":"Xing","year":"2010","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.kint.2018.09.027_bib14","first-page":"2286","article-title":"Eculizumab as rescue therapy in severe resistant lupus nephritis","volume":"54","author":"Pickering","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2018.09.027_bib15","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1681\/ASN.2011121186","article-title":"Pathology after eculizumab in dense deposit disease and C3 GN","volume":"23","author":"Herlitz","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.09.027_bib16","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1681\/ASN.2018020184","article-title":"C5b9 formation on endothelial cells reflects complement defects among patients with renal thrombotic microangiopathy and severe hypertension","volume":"29","author":"Timmermans","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.09.027_bib17","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s10067-017-3823-2","article-title":"Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3: a case report and systematic review","volume":"36","author":"de Holanda","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.kint.2018.09.027_bib18","unstructured":"Clinical Commissioning Policy: Eculizumab in the treatment of recurrence of C3 glomerulopathy post-kidney transplant (all ages). Reference: NHS England: 16054\/P. Available at: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2017\/02\/clin-comms-policy-16054p.pdf. Accessed November 29, 2018."},{"key":"10.1016\/j.kint.2018.09.027_bib19","first-page":"179","article-title":"Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis","volume":"142","author":"Schulze","year":"1993","journal-title":"Am J Pathol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818307890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818307890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:51:54Z","timestamp":1758761514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818307890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0085253818307890"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.09.027","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}